CTRI/2020/07/026631
Completed
未知
A multi centre clinical trial to study the safety and efficacy of herbal combination in covid 19 positive patients in Murugaa hospital and fertility centre
Kumarans fertility centre0 sites30 target enrollmentStarted: TBDLast updated:
Overview
- Phase
- 未知
- Status
- Completed
- Sponsor
- Kumarans fertility centre
- Enrollment
- 30
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •From newborn to 80 years.patients admitted in hospital and in general public who are in home quarantine after testing corona(covid19\) positive.
Exclusion Criteria
- •Covid 19 positive pregnant patients And Carcinoma patients (Any type)
Investigators
Similar Trials
Active, not recruiting
Phase 1
Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment.CTIS2024-515481-13-00Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud20
Not yet recruiting
Phase 1/2
Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment.2024-515481-13-00Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud20
Active, not recruiting
Phase 1
A multi-centre clinical trial evaluating safety and patients' ability to independently use the medicinal product indicated in the treatment of erectile dysfunctioEUCTR2019-003073-25-PLAdamed Pharma S.A.400
Recruiting
Not Applicable
Multicenter clinical study evaluating safety and efficacy of iron chelation therapy in patients with transfusion-induced iron overloadTransfusion-induced iron overloadJPRN-UMIN000002515The National Research Group on Idiopathic Bone Marrow Failure Syndromes in Japan100
Active, not recruiting
Phase 2
Therapeutic drug development program for COVID-19JPRN-jRCTs051200049Iwahori Kota42